Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia

Abstract Background Cannabis-smoking patients with a psychotic disorder have poorer disease outcomes than non-cannabis-smoking patients with poorest outcomes in patients smoking high-potency cannabis (HPC) containing high Δ9-tetrahydrocannabinol (THC) and low cannabidiol (CBD). Quitting cannabis smo...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Jan van Amsterdam, Jojanneke Vervloet, Gerdien de Weert, Victor J. A. Buwalda, Anna E. Goudriaan, Wim van den Brink
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2018-09-01
Serija:	Harm Reduction Journal
Teme:	Schizophrenia Psychosis Cannabis Skunk CBD High-potency cannabis
Online dostop:	http://link.springer.com/article/10.1186/s12954-018-0253-7
Oznake:	Označite Brez oznak, prvi označite!